Torrid market for copycat weight loss drugs could be short-lived

  • 📰 NPR
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 63%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Cheaper versions of Wegovy and Zepbound touted on social media could be fleeting. Copies are legal now because the brand-name drugs are in short supply. But the drugmakers are boosting production.

iframe src="https://www.npr.org/player/embed/nx-s1-5033186/nx-s1-4106eb68-5dc7-44df-b6c2-0d069cac1558" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">Off-brand weight loss drugs containing the same active ingredients as Wegovy and Zepbound seem to be everywhere. Ads for the much cheaper alternatives are popping up on Instagram, in the subway and on TV.

Typically, compounded drugs are made for patients who aren’t served by existing FDA-approved medicines. For example, if someone needed a drug but was allergic to its preservative, a compounding pharmacist could prepare a version without that preservative., compounding pharmacies are usually not allowed to prepare what is “essentially a copy” of an existing FDA approved drug. But there’s an exception.

For larger compounding organizations called outsourcing facilities, they wouldn’t be able to make copies anymore. For smaller ones, they wouldn’t be able to make copies more than four times in one month.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 96. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Drug Companies Have a Sneaky Idea to Get Insurance to Pay for Drugs Like ZepboundScience and Technology News and Videos
출처: futurism - 🏆 85. / 68 더 많은 것을 읽으십시오 »